GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NGM
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for NGM Biopharmaceuticals Inc.
(Updated on Apr 18, 2024)

Hold candidate since Apr 05, 2024 PDF

No changes to the price of NGM Biopharmaceuticals Inc. stock on the last trading day (Thursday, 18th Apr 2024). During the last trading day the stock fluctuated 0% from a day low at $1.54 to a day high of $1.54. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 6.73% during the next 3 months and, with a 90% probability hold a price between $1.50 and $2.14 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NGM Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 04, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The NGM Biopharmaceuticals Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.54 and $1.55. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for NGM Biopharmaceuticals Inc. stock

NGM Biopharmaceuticals Inc. finds support from accumulated volume at $1.53 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: $1.45 (-6.00%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 10 days ago.)

Trading Expectations (NGM) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect NGM Biopharmaceuticals Inc. to open at $1.54, and during the day (based on 14 day Average True Range), to move between $1.51 and $1.57, which gives a possible trading interval of +/-$0.0259 (+/-1.68%) up or down from last closing price. If NGM Biopharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 3.37% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.55 (0.65%) than the support at $1.53 (0.65%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is NGM Biopharmaceuticals Inc. stock A Buy?

NGM Biopharmaceuticals Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for NGM Biopharmaceuticals Inc. of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$1.54 ( 0%) $1.54

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NGM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.54 .
R2 1.54 .
R1 1.54 .
Current price: 1.54
Support S1 1.54 .
S2 1.54 .
S3 1.54 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.63 5.84 %
R2 1.56 1.30 %
R1 1.55 0.649 %
Current price 1.54
Support S1 1.53 -0.649%
S2 1.53 -0.97%
S3 1.52 -1.30%

FAQ

What is the symbol for NGM Biopharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for NGM Biopharmaceuticals Inc. is NGM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell NGM Biopharmaceuticals Inc. Stock?
NGM Biopharmaceuticals Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy NGM Biopharmaceuticals Inc. Stock?
NGM Biopharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy NGM Biopharmaceuticals Inc. Stock.

What's the current price of NGM Biopharmaceuticals Inc. Stock?
As of the end of day on the 2024-04-18, the price of an NGM Biopharmaceuticals Inc. (NGM) share was $1.54.

What is the 52-week high and low for NGM Biopharmaceuticals Inc. Stock?
The 52-week high for NGM Biopharmaceuticals Inc. Stock is $4.69 and the 52-week low is $0.600.

What is the market capitalization of NGM Biopharmaceuticals Inc. Stock?
As of the 2024-04-18, the market capitalization of NGM Biopharmaceuticals Inc. is 128.532M.

When is the next earnings date for NGM Biopharmaceuticals Inc.?
The upcoming earnings date for NGM Biopharmaceuticals Inc. is May 02, 2024.
Click to get the best stock tips daily for free!

About NGM Biopharmaceuticals Inc.

NGM Biopharmaceuticals. NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trials for the treatment of non-alcoholic steatohepatitis (NASH); and MK-3655, an agonistic antibody that ac... NGM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT